ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

19,29
0,36
(1,90%)
Fermé 19 Janvier 10:00PM
19,40
0,11
(0,57%)
Après les heures de négociation: 1:59AM
Graphique avancé
Rendering Error

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
19,29
Prix Achat
18,90
Prix Vente
19,65
Volume échangé
64 463
19,00 Fourchette du Jour 19,61
11,665 Plage de 52 semaines 41,87
Cap du marché
Clôture Veille
18,93
Ouverture
19,05
Dernière Transaction
2
@
19.5
Dernière heure de transaction
Volume financier
US$ 1 239 925
VWAP
19,2347
Volume moyen (3 m)
126 171
Actions en circulation
25 414 898
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,24
Bénéfice par action (BPA)
-8,64
Chiffre d'affairess
26M
Bénéfice net
-219,71M

À propos de Cartesian Therapeutics Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Cartesian Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker RNAC. Le dernier cours de clôture d'Cartesian Therapeutics était de US$18,93. Au cours de la dernière année, les actions de Cartesian Therapeutics ont été négociées dans une fourchette de prix de US$ 11,665 à US$ 41,87.

Cartesian Therapeutics compte actuellement 25 414 898 actions en circulation. La capitalisation boursière d'Cartesian Therapeutics est de US$481,10 million. Cartesian Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.24.

RNAC Dernières nouvelles

Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25 Deepening responses observed over time in Descartes-08-treated participants in Phase 2b trial in myasthenia...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
12.816.979987871416.4920.1216.48217218.00920832CS
40.331.7405063291118.9620.29516.413240218.26351611CS
12-2.81-12.714932126722.126.515.512617119.11993077CS
261.297.166666666671826.512.4811100318.30657212CS
52-9.06-31.957671957728.3541.8711.66523954219.72791679CS
156-4.905-20.27278363324.19542.611.66535983822.60572957CS
260-4.905-20.27278363324.19542.611.66535983822.60572957CS

RNAC - Frequently Asked Questions (FAQ)

What is the current Cartesian Therapeutics share price?
The current share price of Cartesian Therapeutics is US$ 19,29
How many Cartesian Therapeutics shares are in issue?
Cartesian Therapeutics has 25 414 898 shares in issue
What is the market cap of Cartesian Therapeutics?
The market capitalisation of Cartesian Therapeutics is USD 481,1M
What is the 1 year trading range for Cartesian Therapeutics share price?
Cartesian Therapeutics has traded in the range of US$ 11,665 to US$ 41,87 during the past year
What is the PE ratio of Cartesian Therapeutics?
The price to earnings ratio of Cartesian Therapeutics is -2,24
What is the cash to sales ratio of Cartesian Therapeutics?
The cash to sales ratio of Cartesian Therapeutics is 18,96
What is the reporting currency for Cartesian Therapeutics?
Cartesian Therapeutics reports financial results in USD
What is the latest annual turnover for Cartesian Therapeutics?
The latest annual turnover of Cartesian Therapeutics is USD 26M
What is the latest annual profit for Cartesian Therapeutics?
The latest annual profit of Cartesian Therapeutics is USD -219,71M
What is the registered address of Cartesian Therapeutics?
The registered address for Cartesian Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cartesian Therapeutics website address?
The website address for Cartesian Therapeutics is www.selectabio.com
Which industry sector does Cartesian Therapeutics operate in?
Cartesian Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M

RNAC Bilan

Bilan
Rendering Error
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées